Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release to Register With the Securities and Exchange Commission,Inc.
Posted on: 16 Jan 18, Inc. (OTC Pink:HEWA), a Verified Internet Pharmacy Practice Site (VIPPS) accredited online pharmacy licensed and/or authorized to sell in all 50 states serving consumers who pay out of pocket for their prescriptions, today announced that it plans to register with the Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934 (Exchange Act) and, once such registration is effective, will become a public reporting company and file current and periodic reports with the SEC.

The Company previously was registered and filed reports under the Exchange Act but deregistered in April 2017 in order to reduce costs. In addition, the Company intends to apply to the OTC Markets to list its common stock on the OTCQB Market once its registration under the Exchange Act is effective. The Company’s common stock was previously listed on the OTCQB Market but delisted when the Company deregistered with the SEC.

Joseph Peters, President of, stated, “The Board of Directors has determined in light of the Company’s significant progress in improving its balance sheet, increasing gross profit margins and growing sales, to register as a reporting company with the SEC in order to provide shareholders with the best and most current information about the Company. In addition, listing the common stock on the OTC Market will provide additional liquidity for shareholders.”

There can be no assurance that the Company will complete its registration under the Exchange Act and become a public reporting company or that it will be successful in listing its common stock on the OTC Market.

About, Inc. (OTC Pink:HEWA) is a trusted VIPPS accredited online pharmacy based in Florence, Kentucky. The Company is focused on the out of pocket prescription market, which is expected to grow to over $50 billion in 2018. With a mission to provide affordable healthcare to every American by focusing on technology that is revolutionizing prescription delivery, has become the largest VIPPS accredited online pharmacy in the United States exclusively servicing the cash market. is licensed or authorized to ship prescription medication to all 50 states and only sells drugs that are FDA-approved and legal for sale in the United States. Visit online at

Forward-Looking Statements

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results may differ significantly from management's expectations. These forward-looking statements involve risks and uncertainties that include, among others, risks related to competition, management of growth, new products, services and technologies, potential fluctuations in operating results, international expansion, outcomes of legal proceedings and claims, fulfillment center optimization, seasonality, commercial agreements, acquisitions and strategic transactions, foreign exchange rates, system interruption, inventory, government regulation and taxation, and timing of cash flows. More information about factors that potentially could affect's financial results is included in's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent filings.

View source version on

Business Wire

Last updated on: 16/01/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.